2017 Q3 Form 10-K Financial Statement

#000143774917020073 Filed on December 04, 2017

View on sec.gov

Income Statement

Concept 2017 Q3 2016 Q3 2016
Revenue $0.00 -$20.00K $60.00K
YoY Change -100.0% -200.0% -57.14%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $580.0K $210.0K $1.189M
YoY Change 176.19% -74.07% -38.92%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $0.00 $0.00 $14.96K
YoY Change 574.61%
% of Gross Profit
Operating Expenses $580.0K $1.110M $1.189M
YoY Change -47.75% 37.04% -38.92%
Operating Profit -$1.129M
YoY Change -37.51%
Interest Expense -$60.00K -$50.00K $162.8K
YoY Change 20.0% 122.46%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$1.270M -$1.170M -$2.211M
YoY Change 8.55% 46.25% 27.84%
Income Tax
% Of Pretax Income
Net Earnings -$1.270M -$1.170M -$2.211M
YoY Change 8.55% 46.25% 27.84%
Net Earnings / Revenue -3684.61%
Basic Earnings Per Share
Diluted Earnings Per Share -$65.57K -$62.87K -$129.8K
COMMON SHARES
Basic Shares Outstanding 17.03M
Diluted Shares Outstanding 17.03M

Balance Sheet

Concept 2017 Q3 2016 Q3 2016
SHORT-TERM ASSETS
Cash & Short-Term Investments $0.00 $0.00 $20.00
YoY Change -100.0% -99.99%
Cash & Equivalents $1.627K $24.00 $20.00
Short-Term Investments
Other Short-Term Assets $60.00K $260.0K $259.1K
YoY Change -76.92% -88.65% -88.67%
Inventory
Prepaid Expenses $11.73K
Receivables
Other Receivables
Total Short-Term Assets $64.59K $261.6K $261.7K
YoY Change -75.32% -90.29% -89.51%
LONG-TERM ASSETS
Property, Plant & Equipment $4.153K $5.276K $5.280K
YoY Change -21.29% -17.55% -17.5%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $4.400M $3.180M $3.179M
YoY Change 38.36% 1490.0% 1465.12%
Total Long-Term Assets $5.999M $4.049M $4.049M
YoY Change 48.17% 211.21% 169.74%
TOTAL ASSETS
Total Short-Term Assets $64.59K $261.6K $261.7K
Total Long-Term Assets $5.999M $4.049M $4.049M
Total Assets $6.064M $4.310M $4.310M
YoY Change 40.67% 7.9% 7.9%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $620.0K $390.0K $385.4K
YoY Change 58.97% 333.33% 351.79%
Accrued Expenses $90.00K $120.0K $118.8K
YoY Change -25.0%
Deferred Revenue
YoY Change
Short-Term Debt $1.070M $1.160M $1.158M
YoY Change -7.76% 28.89% 28.67%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.801M $1.677M $1.677M
YoY Change 7.37% 68.21% 68.21%
LONG-TERM LIABILITIES
Long-Term Debt $1.980M $2.020M $2.024M
YoY Change -1.98% 20.24% 20.29%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $1.980M $2.020M $2.024M
YoY Change -1.98% 20.24% 20.29%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.801M $1.677M $1.677M
Total Long-Term Liabilities $1.980M $2.020M $2.024M
Total Liabilities $3.779M $3.701M $3.701M
YoY Change 2.1% 38.12% 38.12%
SHAREHOLDERS EQUITY
Retained Earnings -$8.677M -$5.905M
YoY Change 46.94% 59.84%
Common Stock $1.937K $1.703K
YoY Change 13.74% 2.41%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $2.284M $609.0K $609.0K
YoY Change
Total Liabilities & Shareholders Equity $6.064M $4.310M $4.310M
YoY Change 40.67% 7.9% 7.9%

Cashflow Statement

Concept 2017 Q3 2016 Q3 2016
OPERATING ACTIVITIES
Net Income -$1.270M -$1.170M -$2.211M
YoY Change 8.55% 46.25% 27.84%
Depreciation, Depletion And Amortization $0.00 $0.00 $14.96K
YoY Change 574.61%
Cash From Operating Activities -$60.00K $10.00K -$600.9K
YoY Change -700.0% -104.55% -24.18%
INVESTING ACTIVITIES
Capital Expenditures -$30.00K -$200.0K -$725.0K
YoY Change -85.0% 100.0% 200.21%
Acquisitions
YoY Change
Other Investing Activities $0.00 -$40.00K $152.5K
YoY Change -100.0% -200.0% -125.1%
Cash From Investing Activities -$30.00K -$240.0K -$572.5K
YoY Change -87.5% 300.0% -32.57%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $0.00
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 80.00K 220.0K 972.0K
YoY Change -63.64% -42.11% -41.76%
NET CHANGE
Cash From Operating Activities -60.00K 10.00K -600.9K
Cash From Investing Activities -30.00K -240.0K -572.5K
Cash From Financing Activities 80.00K 220.0K 972.0K
Net Change In Cash -10.00K -10.00K -201.3K
YoY Change 0.0% -110.0% -834.86%
FREE CASH FLOW
Cash From Operating Activities -$60.00K $10.00K -$600.9K
Capital Expenditures -$30.00K -$200.0K -$725.0K
Free Cash Flow -$30.00K $210.0K $124.1K
YoY Change -114.29% -275.0% -122.53%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2016 acan Class Of Warrant Or Right Granted During Period Exercise Price
ClassOfWarrantOrRightGrantedDuringPeriodExercisePrice
2.14
CY2017 acan Class Of Warrant Or Right Granted During Period Exercise Price
ClassOfWarrantOrRightGrantedDuringPeriodExercisePrice
1.81
CY2016 acan Class Of Warrant Or Right Granted Weighted Average Remaining Contract Term
ClassOfWarrantOrRightGrantedWeightedAverageRemainingContractTerm
P3Y292D
CY2017 acan Class Of Warrant Or Right Granted Weighted Average Remaining Contract Term
ClassOfWarrantOrRightGrantedWeightedAverageRemainingContractTerm
P3Y36D
CY2015 acan Class Of Warrant Or Right Outstanding Weighted Average Remaining Contract Term
ClassOfWarrantOrRightOutstandingWeightedAverageRemainingContractTerm
P2Y255D
CY2016 acan Class Of Warrant Or Right Outstanding Weighted Average Remaining Contract Term
ClassOfWarrantOrRightOutstandingWeightedAverageRemainingContractTerm
P2Y36D
CY2017 acan Amortization Of Equity Instruments Issued To Lessor
AmortizationOfEquityInstrumentsIssuedToLessor
39456
CY2016 acan Amortization Of Equity Instruments Issued To Lessor
AmortizationOfEquityInstrumentsIssuedToLessor
CY2017Q3 acan Assets Heldforsale Not Part Of Disposal Group Noncurrent
AssetsHeldforsaleNotPartOfDisposalGroupNoncurrent
1611312
CY2017Q3 acan Class Of Warrant Or Right Exercisable
ClassOfWarrantOrRightExercisable
6526000
CY2017Q3 acan Class Of Warrant Or Right Exercisable Exercise Price
ClassOfWarrantOrRightExercisableExercisePrice
5.18
CY2017 acan Class Of Warrant Or Right Exercisable Weighted Average Remaining Contract Term
ClassOfWarrantOrRightExercisableWeightedAverageRemainingContractTerm
P2Y
CY2016 acan Class Of Warrant Or Right Granted During Period
ClassOfWarrantOrRightGrantedDuringPeriod
1750000
CY2017 acan Class Of Warrant Or Right Granted During Period
ClassOfWarrantOrRightGrantedDuringPeriod
5825000
CY2017 acan Class Of Warrant Or Right Outstanding Weighted Average Remaining Contract Term
ClassOfWarrantOrRightOutstandingWeightedAverageRemainingContractTerm
P2Y146D
CY2017Q3 acan Class Of Warrant Or Right Vested And Expected To Vest
ClassOfWarrantOrRightVestedAndExpectedToVest
10166000
CY2017Q3 acan Class Of Warrant Or Right Vested And Expected To Vest Weighted Average Exercise Price
ClassOfWarrantOrRightVestedAndExpectedToVestWeightedAverageExercisePrice
3.68
CY2017 acan Class Of Warrant Or Right Vested And Expected To Vest Weighted Average Remaining Contract Term
ClassOfWarrantOrRightVestedAndExpectedToVestWeightedAverageRemainingContractTerm
P2Y146D
CY2017 acan Debt Discount Premium
DebtDiscountPremium
CY2016 acan Debt Discount Premium
DebtDiscountPremium
35250
CY2017 acan Debt Discount Premium Due To Debt Modifications
DebtDiscountPremiumDueToDebtModifications
CY2016 acan Debt Discount Premium Due To Debt Modifications
DebtDiscountPremiumDueToDebtModifications
72651
CY2017Q3 acan Debt Instrument Related Parties Unamortized Discount
DebtInstrumentRelatedPartiesUnamortizedDiscount
47037
CY2016Q3 acan Debt Instrument Related Parties Unamortized Discount
DebtInstrumentRelatedPartiesUnamortizedDiscount
72651
CY2017Q3 acan Deferred Tax Assets Temporary Difference Gross
DeferredTaxAssetsTemporaryDifferenceGross
2506708
CY2016Q3 acan Deferred Tax Assets Temporary Difference Gross
DeferredTaxAssetsTemporaryDifferenceGross
1165592
CY2017Q3 acan Deferred Tax Assets Temporary Difference Net Operating Loss
DeferredTaxAssetsTemporaryDifferenceNetOperatingLoss
1789958
CY2016Q3 acan Deferred Tax Assets Temporary Difference Net Operating Loss
DeferredTaxAssetsTemporaryDifferenceNetOperatingLoss
1156331
CY2017Q3 acan Deferred Tax Assets Temporary Difference Other
DeferredTaxAssetsTemporaryDifferenceOther
716750
CY2016Q3 acan Deferred Tax Assets Temporary Difference Other
DeferredTaxAssetsTemporaryDifferenceOther
9261
CY2017Q3 acan Deferred Tax Assets Temporary Difference Valuation Allowance
DeferredTaxAssetsTemporaryDifferenceValuationAllowance
2506708
CY2016Q3 acan Deferred Tax Assets Temporary Difference Valuation Allowance
DeferredTaxAssetsTemporaryDifferenceValuationAllowance
1165592
CY2017 acan Deferred Tax Assets Valuation Allowance Percent Offset
DeferredTaxAssetsValuationAllowancePercentOffset
1
CY2017Q3 acan Depoists On Land Noncurrent
DepoistsOnLandNoncurrent
2782047
CY2017 dei Amendment Flag
AmendmentFlag
false
CY2017 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2017 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2017
CY2017 dei Document Period End Date
DocumentPeriodEndDate
2017-09-30
CY2017 dei Document Type
DocumentType
10-K
CY2017Q1 dei Entity Public Float
EntityPublicFloat
36959000
CY2016 acan Effective Income Tax Rate Reconciliation Net Operating Loss Percent
EffectiveIncomeTaxRateReconciliationNetOperatingLossPercent
-0.3706
CY2016Q3 acan Depoists On Land Noncurrent
DepoistsOnLandNoncurrent
925000
CY2017 acan Effective Income Tax Rate Reconciliation Federal Statutory And State Combined Income Tax Rate Percent
EffectiveIncomeTaxRateReconciliationFederalStatutoryAndStateCombinedIncomeTaxRatePercent
0.3706
CY2016 acan Effective Income Tax Rate Reconciliation Federal Statutory And State Combined Income Tax Rate Percent
EffectiveIncomeTaxRateReconciliationFederalStatutoryAndStateCombinedIncomeTaxRatePercent
0.3706
CY2017 acan Effective Income Tax Rate Reconciliation Net Operating Loss Percent
EffectiveIncomeTaxRateReconciliationNetOperatingLossPercent
-0.3706
CY2016Q4 acan Equity Units Number Of Shares Of Common Stock In Each Unit
EquityUnitsNumberOfSharesOfCommonStockInEachUnit
1
CY2017Q3 acan Equity Units Number Of Shares Of Common Stock In Each Unit
EquityUnitsNumberOfSharesOfCommonStockInEachUnit
1
CY2016Q4 acan Equity Units Price Per Unit
EquityUnitsPricePerUnit
1
CY2017Q3 acan Equity Units Price Per Unit
EquityUnitsPricePerUnit
2
CY2016Q4 acan Equity Units Subscribed But Unissued Gross Proceeds Receivable
EquityUnitsSubscribedButUnissuedGrossProceedsReceivable
2000000
CY2017Q3 acan Equity Units Subscribed But Unissued Gross Proceeds Receivable
EquityUnitsSubscribedButUnissuedGrossProceedsReceivable
370000
CY2016Q4 acan Equity Units Value Subscriptions
EquityUnitsValueSubscriptions
2000000
CY2017Q3 acan Equity Units Value Subscriptions
EquityUnitsValueSubscriptions
185000
CY2017 acan Fund Requires For Operation Over The Next Twelve Months
FundRequiresForOperationOverTheNextTwelveMonths
7000000
CY2017 acan Increase Decrease In Bank Overdrafts
IncreaseDecreaseInBankOverdrafts
-10616
CY2016 acan Increase Decrease In Bank Overdrafts
IncreaseDecreaseInBankOverdrafts
CY2017 acan Increase Decrease In Interest Payable Related Party Net
IncreaseDecreaseInInterestPayableRelatedPartyNet
-24827
CY2016 acan Increase Decrease In Interest Payable Related Party Net
IncreaseDecreaseInInterestPayableRelatedPartyNet
109825
CY2017Q3 acan Interest Payable Related Party Current
InterestPayableRelatedPartyCurrent
84998
CY2016Q3 acan Interest Payable Related Party Current
InterestPayableRelatedPartyCurrent
109825
CY2017Q3 acan Land Held For Use
LandHeldForUse
1611312
CY2016Q3 acan Land Held For Use
LandHeldForUse
2250809
CY2017Q3 acan Notes And Loans Receivable Including Related Parties Net Current
NotesAndLoansReceivableIncludingRelatedPartiesNetCurrent
CY2016Q3 acan Notes And Loans Receivable Including Related Parties Net Current
NotesAndLoansReceivableIncludingRelatedPartiesNetCurrent
247378
CY2017Q3 acan Notes And Loans Receivable Including Related Parties Net Noncurrent
NotesAndLoansReceivableIncludingRelatedPartiesNetNoncurrent
905642
CY2016Q3 acan Notes And Loans Receivable Including Related Parties Net Noncurrent
NotesAndLoansReceivableIncludingRelatedPartiesNetNoncurrent
838008
CY2017Q3 acan Notes And Loans Receivable Net
NotesAndLoansReceivableNet
905642
CY2016Q3 acan Notes And Loans Receivable Net
NotesAndLoansReceivableNet
1085386
CY2017Q3 acan Notes Loans And Financing Receivable Net Related Parties Noncurrent
NotesLoansAndFinancingReceivableNetRelatedPartiesNoncurrent
125327
CY2016Q3 acan Notes Loans And Financing Receivable Net Related Parties Noncurrent
NotesLoansAndFinancingReceivableNetRelatedPartiesNoncurrent
57693
CY2014Q1 acan Ownership Percentage Transfered
OwnershipPercentageTransfered
0.93
CY2017 acan Reclassification Of Debt To Related Party Debt
ReclassificationOfDebtToRelatedPartyDebt
CY2016 acan Reclassification Of Debt To Related Party Debt
ReclassificationOfDebtToRelatedPartyDebt
521297
CY2017 acan Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercises In Period Weighted Average Remaining Contractual Term
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisesInPeriodWeightedAverageRemainingContractualTerm
P2Y
CY2017 acan Sharebased Compensation Arrangement By Sharebased Payment Award Options Grants In Period Weighted Average Remaining Contractual Term
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualTerm
P4Y
CY2017 acan Stock And Warrants Issued During Period Value Consideration For Sale Leaseback Transaction
StockAndWarrantsIssuedDuringPeriodValueConsiderationForSaleLeasebackTransaction
1972966
CY2016 acan Stock And Warrants Issued During Period Value Consideration For Sale Leaseback Transaction
StockAndWarrantsIssuedDuringPeriodValueConsiderationForSaleLeasebackTransaction
CY2017Q3 acan Stock Issued During Period Value Issued For Cash Net
StockIssuedDuringPeriodValueIssuedForCashNet
2176274
CY2017 acan Stock Issued During Period Value Issued To Lessor
StockIssuedDuringPeriodValueIssuedToLessor
1972966
CY2017Q3 acan Working Capital Deficit
WorkingCapitalDeficit
-2771894
CY2016Q3 acan Working Capital Deficit
WorkingCapitalDeficit
-1735989
CY2017Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
624623
CY2016Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
385380
CY2017Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
3704
CY2016Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2581
CY2017Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
10959188
CY2016Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
6512244
CY2017 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
CY2016 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
756637
CY2016 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
131075
CY2017 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
37450
CY2017Q3 us-gaap Allowance For Notes And Loans Receivable Noncurrent
AllowanceForNotesAndLoansReceivableNoncurrent
469699
CY2016Q3 us-gaap Allowance For Notes And Loans Receivable Noncurrent
AllowanceForNotesAndLoansReceivableNoncurrent
469699
CY2017 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
9636
CY2016 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
0
CY2014Q3 us-gaap Area Of Land
AreaOfLand
5
CY2017Q3 us-gaap Assets
Assets
6063558
CY2016Q3 us-gaap Assets
Assets
4310366
CY2017Q3 us-gaap Assets Current
AssetsCurrent
64586
CY2016Q3 us-gaap Assets Current
AssetsCurrent
261649
CY2017Q3 us-gaap Assets Fair Value Disclosure Nonrecurring
AssetsFairValueDisclosureNonrecurring
0
CY2016Q3 us-gaap Assets Fair Value Disclosure Nonrecurring
AssetsFairValueDisclosureNonrecurring
0
CY2016Q3 us-gaap Assets Fair Value Disclosure Recurring
AssetsFairValueDisclosureRecurring
0
CY2017Q3 us-gaap Assets Fair Value Disclosure Recurring
AssetsFairValueDisclosureRecurring
0
CY2017Q3 us-gaap Capitalized Computer Software Accumulated Amortization
CapitalizedComputerSoftwareAccumulatedAmortization
28820
CY2016Q3 us-gaap Capitalized Computer Software Accumulated Amortization
CapitalizedComputerSoftwareAccumulatedAmortization
14986
CY2017Q3 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
12680
CY2016Q3 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
26514
CY2017Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1627
CY2016Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
24
CY2015Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
201353
CY2017 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
1603
CY2016 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-201329
CY2015Q3 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
8.92
CY2016Q3 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
6.19
CY2017Q3 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
3.68
CY2015Q3 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
2591000
CY2016Q3 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
4341000
CY2017Q3 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
10166000
CY2017Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2016Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2017Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2016Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2017Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2016Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2017Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
19366000
CY2016Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
17031000
CY2017Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
19366000
CY2016Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
17031000
CY2017Q3 us-gaap Common Stock Value
CommonStockValue
1937
CY2016Q3 us-gaap Common Stock Value
CommonStockValue
1703
CY2017 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:0pt;margin-right:5.4pt;margin-top:0pt;text-align:justify;"><div style="display: inline; font-style: italic;">Concentration of Credit Risks</div><div style="display: inline; font-family:Times New Roman, Times, serif;font-size:10pt;"><div style="display: inline; font-style: italic;"> and Significant Customers</div></div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:justify;">Financial instruments that potentially subject us to concentrations of credit risk co<div style="display: inline; font-family:Times New Roman, Times, serif;font-size:10pt;">nsist principally of cash, notes receivables, deposits, accounts receivables and notes receivable. We place our cash with high credit quality financial institutions. As of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2017, </div>we had outstanding notes receivable of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$125,327</div> with Coastal Compassion Inc., and a note and a receivable in the amount of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$1,250,014</div> with WGP (exclusive of provision for doubtful accounts of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$469,699</div>).&nbsp; See Note <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3</div> for a discussion of our provision for doubtful accounts for amounts owed from WGP.</div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">For <div style="display: inline; font-family:Times New Roman, Times, serif;font-size:10pt;">the years ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2017 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> all of the Company&#x2019;s revenue was earned from <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">one</div> </div>customer, <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4900</div> Jackson, LLC. </div></div></div></div></div></div>
CY2017 us-gaap Construction In Progress Expenditures Incurred But Not Yet Paid
ConstructionInProgressExpendituresIncurredButNotYetPaid
179308
CY2016 us-gaap Construction In Progress Expenditures Incurred But Not Yet Paid
ConstructionInProgressExpendituresIncurredButNotYetPaid
CY2017Q3 us-gaap Construction In Progress Gross
ConstructionInProgressGross
680028
CY2016Q3 us-gaap Construction In Progress Gross
ConstructionInProgressGross
CY2017Q3 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
0
CY2016Q3 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
35250
CY2017Q3 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
0
CY2016Q3 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
0
CY2017Q3 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
928986
CY2016Q3 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
431968
CY2017Q3 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0
CY2016Q3 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0
CY2017Q3 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0
CY2016Q3 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0
CY2017Q3 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
663358
CY2016Q3 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
428536
CY2017Q3 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
265628
CY2016Q3 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
3432
CY2017Q3 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
928986
CY2016Q3 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
431968
CY2017 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
14957
CY2016 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
14956
CY2017 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.15
CY2016 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.13
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.15
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.13
CY2017 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
CY2016 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
CY2017 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.34
CY2016 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.34
CY2017 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.0306
CY2016 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.0306
CY2017Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
0
CY2017 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
CY2016 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-991939
CY2017 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1412314
CY2016 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
583739
CY2017 us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
639497
CY2016 us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
0
CY2017 us-gaap Income Taxes Paid
IncomeTaxesPaid
0
CY2016 us-gaap Income Taxes Paid
IncomeTaxesPaid
0
CY2017 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
49319
CY2016 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
300082
CY2017 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
-2521
CY2016 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
-3454
CY2017 us-gaap Increase Decrease In Customer Advances
IncreaseDecreaseInCustomerAdvances
CY2016 us-gaap Increase Decrease In Customer Advances
IncreaseDecreaseInCustomerAdvances
-128744
CY2017 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
-7669
CY2016 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
8924
CY2017 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
4772
CY2016 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
3211
CY2017 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-25230
CY2016 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-24032
CY2017 us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
0
CY2016 us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
725000
CY2017 us-gaap Interest Costs Capitalized
InterestCostsCapitalized
28697
CY2016 us-gaap Interest Costs Capitalized
InterestCostsCapitalized
0
CY2017 us-gaap Interest Expense
InterestExpense
201367
CY2016 us-gaap Interest Expense
InterestExpense
162834
CY2017 us-gaap Interest Expense Related Party
InterestExpenseRelatedParty
143917
CY2016 us-gaap Interest Expense Related Party
InterestExpenseRelatedParty
109825
CY2017 us-gaap Interest Paid Net
InterestPaidNet
396841
CY2016 us-gaap Interest Paid Net
InterestPaidNet
151925
CY2017Q3 us-gaap Interest Payable Current
InterestPayableCurrent
86253
CY2016Q3 us-gaap Interest Payable Current
InterestPayableCurrent
118749
CY2017Q3 us-gaap Interest Receivable Current
InterestReceivableCurrent
CY2016Q3 us-gaap Interest Receivable Current
InterestReceivableCurrent
2521
CY2017 us-gaap Investment Income Interest
InvestmentIncomeInterest
11086
CY2016 us-gaap Investment Income Interest
InvestmentIncomeInterest
183255
CY2017Q3 us-gaap Liabilities
Liabilities
3779258
CY2016Q3 us-gaap Liabilities
Liabilities
3701350
CY2017Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
6063558
CY2016Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
4310366
CY2017Q3 us-gaap Liabilities Current
LiabilitiesCurrent
1800575
CY2016Q3 us-gaap Liabilities Current
LiabilitiesCurrent
1677053
CY2016Q3 us-gaap Liabilities Fair Value Disclosure Nonrecurring
LiabilitiesFairValueDisclosureNonrecurring
0
CY2017Q3 us-gaap Liabilities Fair Value Disclosure Nonrecurring
LiabilitiesFairValueDisclosureNonrecurring
0
CY2016Q3 us-gaap Liabilities Fair Value Disclosure Recurring
LiabilitiesFairValueDisclosureRecurring
0
CY2017Q3 us-gaap Liabilities Fair Value Disclosure Recurring
LiabilitiesFairValueDisclosureRecurring
0
CY2017 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
10712
CY2016 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
21312
CY2017 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2070527
CY2016 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
972044
CY2017 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-320976
CY2016 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-572510
CY2017 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1747948
CY2016 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-600863
CY2017 us-gaap Net Income Loss
NetIncomeLoss
-2771894
CY2016 us-gaap Net Income Loss
NetIncomeLoss
-2210764
us-gaap Net Income Loss
NetIncomeLoss
-2771894
us-gaap Net Income Loss
NetIncomeLoss
-2210764
CY2017Q3 us-gaap Notes And Loans Receivable Net Current
NotesAndLoansReceivableNetCurrent
CY2016Q3 us-gaap Notes And Loans Receivable Net Current
NotesAndLoansReceivableNetCurrent
247378
CY2017Q3 us-gaap Notes And Loans Receivable Net Noncurrent
NotesAndLoansReceivableNetNoncurrent
780315
CY2016Q3 us-gaap Notes And Loans Receivable Net Noncurrent
NotesAndLoansReceivableNetNoncurrent
780315
CY2017Q3 us-gaap Notes Payable Current
NotesPayableCurrent
1070000
CY2016Q3 us-gaap Notes Payable Current
NotesPayableCurrent
1157997
CY2017Q3 us-gaap Notes Payable Related Parties Noncurrent
NotesPayableRelatedPartiesNoncurrent
1978683
CY2016Q3 us-gaap Notes Payable Related Parties Noncurrent
NotesPayableRelatedPartiesNoncurrent
2024297
CY2017 us-gaap Operating Expenses
OperatingExpenses
2477696
CY2016 us-gaap Operating Expenses
OperatingExpenses
1189421
CY2017 us-gaap Operating Income Loss
OperatingIncomeLoss
-2437696
CY2016 us-gaap Operating Income Loss
OperatingIncomeLoss
-1129421
CY2017Q3 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
16734414
CY2017Q3 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
342406
CY2017Q3 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
341496
CY2017Q3 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
341496
CY2017Q3 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
341496
CY2017Q3 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
341496
CY2017Q3 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
15026024
CY2017Q3 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
4370404
CY2016Q3 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
2551748
CY2016Q3 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2017Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
5000
CY2016Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
11726
CY2017Q3 us-gaap Prepaid Rent
PrepaidRent
57959
CY2017Q3 us-gaap Other Notes Payable Current
OtherNotesPayableCurrent
19699
CY2016Q3 us-gaap Other Notes Payable Current
OtherNotesPayableCurrent
14927
CY2017 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-334198
CY2016 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-1081343
CY2017 us-gaap Payments For Construction In Process
PaymentsForConstructionInProcess
500720
CY2016 us-gaap Payments For Construction In Process
PaymentsForConstructionInProcess
CY2016Q4 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
193726
CY2014Q3 us-gaap Payments To Acquire Land Held For Use
PaymentsToAcquireLandHeldForUse
2250000
CY2017Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2016Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2017Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000
CY2016Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000
CY2017Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2016Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2017Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2016Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2017Q3 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2016Q3 us-gaap Prepaid Rent
PrepaidRent
CY2017 us-gaap Proceeds From Collection Of Notes Receivable
ProceedsFromCollectionOfNotesReceivable
247378
CY2016 us-gaap Proceeds From Collection Of Notes Receivable
ProceedsFromCollectionOfNotesReceivable
338927
CY2017 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
2176274
CY2016 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
CY2017 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
104657
CY2016 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
724544
CY2017 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
0
CY2016 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
247500
CY2017 us-gaap Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
-67634
CY2016 us-gaap Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
-57693
CY2017 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
37500
CY2016 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0
CY2017 us-gaap Professional Fees
ProfessionalFees
415173
CY2016 us-gaap Professional Fees
ProfessionalFees
571141
CY2017Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4153
CY2016Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
5276
CY2017 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
CY2016 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
13229
CY2017 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
227904
CY2016 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
0
CY2017 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
20000
CY2016 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
0
CY2017Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-8676825
CY2016Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-5904931
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
19007371
CY2017 us-gaap Revenues
Revenues
40000
CY2016 us-gaap Revenues
Revenues
60000
CY2017 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
40000
CY2016 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
60000
CY2017Q3 us-gaap Security Deposit
SecurityDeposit
3110
CY2016Q3 us-gaap Security Deposit
SecurityDeposit
3110
CY2017 us-gaap Share Based Compensation
ShareBasedCompensation
260438
CY2016 us-gaap Share Based Compensation
ShareBasedCompensation
140249
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
150000
CY2015Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1205000
CY2016Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1205000
CY2017Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1305000
CY2015Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
8.70
CY2016Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
8.70
CY2017Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
8.29
CY2017Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
1305000
CY2017Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
8.29
CY2017Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
1305000
CY2017Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
8.29
CY2017 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.75
CY2016 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
CY2017 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
2.50
CY2015 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P1Y182D
CY2016 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P1Y182D
CY2017 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P328D
CY2017 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P328D
CY2017 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P328D
CY2017 us-gaap Stock Issued1
StockIssued1
CY2016 us-gaap Stock Issued1
StockIssued1
500000
CY2017 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
50000
CY2016 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1364539
CY2017 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
37500
CY2016 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
9173
CY2017 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
222988
CY2017Q3 us-gaap Stockholders Equity
StockholdersEquity
2284300
CY2016Q3 us-gaap Stockholders Equity
StockholdersEquity
609016
CY2015Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1314993
CY2016Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
609016
CY2017Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
2284300
CY2017Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2017 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
0
CY2017 us-gaap Use Of Estimates
UseOfEstimates
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><div style="display: inline; font-style: italic;">Use o<div style="display: inline; font-family:Times New Roman, Times, serif;font-size:10pt;">f Estimates</div></div></div> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:justify;">The preparation of consolidated financial statements in conformity with U.S. generally accepted accounting principles requires management to make estimates and assumptions that affect<div style="display: inline; font-family:Times New Roman, Times, serif;font-size:10pt;">&nbsp;the&nbsp;reported&nbsp;amounts of assets and&nbsp;liabilities and disclosure of contingent&nbsp;assets and liabilities at the date of the consolidated financial statements and the&nbsp;reported amounts of revenues and expenses&nbsp;during the reporting period. The more significant estimates and assumptions made by management are valuation of equity instruments, deferred tax asset valuation and allowance and collectability of long-lived assets. Actual results could differ from those estimates as the current economic environment has increased the degree of uncertainty inherent in these estimates and assumptions.&nbsp;&nbsp;See Note <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3</div> for a discussion of our provision for doubtful accounts for amount amounts owed from WGP.</div></div></div></div></div></div>
CY2017 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
497018
CY2016 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
27396
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
17031000
CY2017 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
19007371
CY2016 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
17031000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
19007371
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
17031000

Files In Submission

Name View Source Status
0001437749-17-020073-index-headers.html Edgar Link pending
0001437749-17-020073-index.html Edgar Link pending
0001437749-17-020073.txt Edgar Link pending
0001437749-17-020073-xbrl.zip Edgar Link pending
a01.jpg Edgar Link pending
a02.jpg Edgar Link pending
a03.jpg Edgar Link pending
a04.jpg Edgar Link pending
a05.jpg Edgar Link pending
a06.jpg Edgar Link pending
a07.jpg Edgar Link pending
a08.jpg Edgar Link pending
a09.jpg Edgar Link pending
a10.jpg Edgar Link pending
a11.jpg Edgar Link pending
acan-20170930.xml Edgar Link completed
acan-20170930.xsd Edgar Link pending
acan-20170930_cal.xml Edgar Link unprocessable
acan-20170930_def.xml Edgar Link unprocessable
acan-20170930_lab.xml Edgar Link unprocessable
acan-20170930_pre.xml Edgar Link unprocessable
acan20170930_10k.htm Edgar Link pending
ex_101123.htm Edgar Link pending
ex_101124.htm Edgar Link pending
ex_101125.htm Edgar Link pending
ex_101312.htm Edgar Link pending
ex_101314.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending